Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV003281805 | SCV003969313 | uncertain significance | Inborn genetic diseases | 2023-04-26 | criteria provided, single submitter | clinical testing | The c.9628C>G (p.Q3210E) alteration is located in exon 60 (coding exon 60) of the RELN gene. This alteration results from a C to G substitution at nucleotide position 9628, causing the glutamine (Q) at amino acid position 3210 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV003779969 | SCV004583432 | likely benign | Norman-Roberts syndrome; Familial temporal lobe epilepsy 7 | 2023-12-13 | criteria provided, single submitter | clinical testing |